Literature DB >> 28194435

Foxp3 drives oxidative phosphorylation and protection from lipotoxicity.

Duncan Howie1, Stephen Paul Cobbold1, Elizabeth Adams1, Annemieke Ten Bokum1, Andra Stefania Necula1, Wei Zhang2, Honglei Huang3, David J Roberts3,4, Benjamin Thomas1, Svenja S Hester1, David J Vaux1, Alexander G Betz1, Herman Waldmann1.   

Abstract

Tregs can adopt a catabolic metabolic program with increased capacity for fatty acid oxidation-fueled oxidative phosphorylation (OXPHOS). It is unclear why this form of metabolism is favored in Tregs and, more specifically, whether this program represents an adaptation to the environment and developmental cues or is "hardwired" by Foxp3. Here we show, using metabolic analysis and an unbiased mass spectroscopy-based proteomics approach, that Foxp3 is both necessary and sufficient to program Treg-increased respiratory capacity and Tregs' increased ability to utilize fatty acids to fuel oxidative phosphorylation. Foxp3 drives upregulation of components of all the electron transport complexes, increasing their activity and ATP generation by oxidative phosphorylation. Increased fatty acid β-oxidation also results in selective protection of Foxp3+ cells from fatty acid-induced cell death. This observation may provide novel targets for modulating Treg function or selection therapeutically.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28194435      PMCID: PMC5291728          DOI: 10.1172/jci.insight.89160

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  64 in total

1.  Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.

Authors:  Maximilian Zeyda; Joakim Huber; Gerhard Prager; Thomas M Stulnig
Journal:  Obesity (Silver Spring)       Date:  2010-05-27       Impact factor: 5.002

2.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

3.  Comparative evaluation of label-free SINQ normalized spectral index quantitation in the central proteomics facilities pipeline.

Authors:  David C Trudgian; Gabriela Ridlova; Roman Fischer; Mukram M Mackeen; Nicola Ternette; Oreste Acuto; Benedikt M Kessler; Benjamin Thomas
Journal:  Proteomics       Date:  2011-06-08       Impact factor: 3.984

4.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.

Authors:  Timothy J Sadlon; Bridget G Wilkinson; Stephen Pederson; Cheryl Y Brown; Suzanne Bresatz; Tessa Gargett; Elizabeth L Melville; Kaimen Peng; Richard J D'Andrea; Gary G Glonek; Gregory J Goodall; Heddy Zola; M Frances Shannon; Simon C Barry
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

8.  Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.

Authors:  Jeffrey Deiuliis; Zubair Shah; Nilay Shah; Bradley Needleman; Dean Mikami; Vimal Narula; Kyle Perry; Jeffrey Hazey; Thomas Kampfrath; Madhukar Kollengode; Qinghua Sun; Abhay R Satoskar; Carey Lumeng; Susan Moffatt-Bruce; Sanjay Rajagopalan
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

9.  Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance.

Authors:  Adrian R Kendal; Ye Chen; Frederico S Regateiro; Jianbo Ma; Elizabeth Adams; Stephen P Cobbold; Shohei Hori; Herman Waldmann
Journal:  J Exp Med       Date:  2011-08-29       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  67 in total

Review 1.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 2.  HIV Persistence in Adipose Tissue Reservoirs.

Authors:  Jacob Couturier; Dorothy E Lewis
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 3.  Determinants of Tissue-Specific Metabolic Adaptation of T Cells.

Authors:  Siva Karthik Varanasi; Sushmitha Vijaya Kumar; Barry T Rouse
Journal:  Cell Metab       Date:  2020-11-11       Impact factor: 27.287

Review 4.  Regulatory T Cells: the Many Faces of Foxp3.

Authors:  Peter Georgiev; Louis-Marie Charbonnier; Talal A Chatila
Journal:  J Clin Immunol       Date:  2019-09-02       Impact factor: 8.317

5.  Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent Mechanism.

Authors:  Dongkyun Kim; Quang Tam Nguyen; Juyeun Lee; Sung Hwan Lee; Allison Janocha; Sohee Kim; Hongnga T Le; Nina Dvorina; Kelly Weiss; Mark J Cameron; Kewal Asosingh; Serpil C Erzurum; William M Baldwin; Ju-Seog Lee; Booki Min
Journal:  Immunity       Date:  2020-07-23       Impact factor: 31.745

6.  Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

Authors:  Alessia Angelin; Luis Gil-de-Gómez; Satinder Dahiya; Jing Jiao; Lili Guo; Matthew H Levine; Zhonglin Wang; William J Quinn; Piotr K Kopinski; Liqing Wang; Tatiana Akimova; Yujie Liu; Tricia R Bhatti; Rongxiang Han; Benjamin L Laskin; Joseph A Baur; Ian A Blair; Douglas C Wallace; Wayne W Hancock; Ulf H Beier
Journal:  Cell Metab       Date:  2017-04-13       Impact factor: 27.287

Review 7.  Dysfunctional T cell metabolism in the tumor microenvironment.

Authors:  Kathryn E Beckermann; Stephanie O Dudzinski; Jeffrey C Rathmell
Journal:  Cytokine Growth Factor Rev       Date:  2017-04-23       Impact factor: 7.638

8.  Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis.

Authors:  Saige L Pompura; Allon Wagner; Alexandra Kitz; Jacob LaPerche; Nir Yosef; Margarita Dominguez-Villar; David A Hafler
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 9.  Lipids in the tumor microenvironment: From cancer progression to treatment.

Authors:  Kevin C Corn; McKenzie A Windham; Marjan Rafat
Journal:  Prog Lipid Res       Date:  2020-08-11       Impact factor: 16.195

10.  Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets.

Authors:  Bhavana Priyadharshini; Michael Loschi; Ryan H Newton; Jian-Wen Zhang; Kelsey K Finn; Valerie A Gerriets; Alexandria Huynh; Jeffery C Rathmell; Bruce R Blazar; Laurence A Turka
Journal:  J Immunol       Date:  2018-09-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.